e-learning
resources
ERJ
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
COVID-19 and biologics in severe asthma: data from the Belgian Severe Asthma Registry
Shane Hanon, Guy Brusselle, Maud Deschampheleire, Renaud Louis, Alain Michils, Rudi Peché, Charles Pilette, Peter Rummens, Daniel Schuermans, Hélène Simonis, Olivier Vandenplas, Florence Schleich
Source:
Eur Respir J, 56 (6) 2002857; 10.1183/13993003.02857-2020
Journal Issue:
December
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Shane Hanon, Guy Brusselle, Maud Deschampheleire, Renaud Louis, Alain Michils, Rudi Peché, Charles Pilette, Peter Rummens, Daniel Schuermans, Hélène Simonis, Olivier Vandenplas, Florence Schleich. COVID-19 and biologics in severe asthma: data from the Belgian Severe Asthma Registry. Eur Respir J, 56 (6) 2002857; 10.1183/13993003.02857-2020
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Respiratory sequelae of preterm birth across the life span
Time to breathe: Challenges in the successful management of asthma during conception, pregnancy and delivery
Related content which might interest you:
The German Severe Asthma Registry: Obesity is associated with asthma parameters
Source: Virtual Congress 2020 – Phenotypes of asthma and COPD
Year: 2020
The Severe Asthma Registry – German data
Source: International Congress 2018 – Physiological and biological insights in asthma
Year: 2018
Impact of bronchiectasis on severe asthma: data from the “Severe Asthma Network Italy” (SANI) registry
Source: International Congress 2018 – Determinants and monitoring of asthma control
Year: 2018
Gender and its relation to asthma phenotype and comorbidities in difficult-to-control asthma patients from Czech National Severe Asthma Registry
Source: Annual Congress 2008 - COPD epidemiology
Year: 2008
Triple combination therapy in severe asthma: overview from the Italian Registry Severe Asthma (IRSA)
Source: Virtual Congress 2021 – Advances in asthma treatment
Year: 2021
Chronic oral corticosteroids use and persistent eosinophilia in severe asthma. The Belgian Severe Asthma Registry.
Source: Virtual Congress 2020 – Phenotypes of asthma and COPD
Year: 2020
Proportion of complete responders after one year of treatment with biologics for severe asthma - Results from the nationwide Danish Severe Asthma Register.
Source: Virtual Congress 2020 – Personalised treatment of obstructive diseases
Year: 2020
Asthma as a co-morbidity and cause of bronchiectasis: data from the European Bronchiectasis Registry (EMBARC).
Source: Virtual Congress 2020 – Non-tuberculous mycobacterial infections and bronchiectasis
Year: 2020
Characteristics of severe asthmatics treated with omalizumab, mepolizumab or no biotherapy. Data from the Belgian Severe Asthma Registry (BSAR).
Source: International Congress 2019 – Exacerbations and clinical impact of airway diseases
Year: 2019
Swiss Severe Asthma Registry (SSAR)- Good asthma control and high number of exacerbations. How does this fit?
Source: Virtual Congress 2021 – Severe asthma: evaluation using patient-reported outcome measures (PROMs) and biomarkers, comorbidities and treatments
Year: 2021
Late Breaking Abstract - Characteristics of T2-biomarker low severe asthma patients in the UK Severe Asthma Registry (UKSAR)
Source: International Congress 2019 – Asthma epidemiology in the 21st century
Year: 2019
Characterization of asthma exacerbations in outpatients – National survey
Source: International Congress 2015 – Clinical assessment in asthma and COPD
Year: 2015
Epidemiology and characteristics of severe asthma exacerbations in children
Source: International Congress 2014 – Paediatric asthma: what is new for the clinician?
Year: 2014
U-BIOPRED: Clinical characteristics of children with severe asthma (SA) and severe pre-school wheeze (SPSW)
Source: International Congress 2014 – More paediatric asthma
Year: 2014
Characteristics of the frequent exacerbator in U-BIOPRED adult severe asthma cohort
Source: International Congress 2015 – Phenotyping asthma with biomarkers
Year: 2015
Patients with allergic and eosinophilic asthma in the German severe asthma registry
Source: International Congress 2015 – Asthma and lung immunology
Year: 2015
Gender differences in patients with severe asthma in real-life setting: data from the Severe Asthma Network in Italy (SANI) registry
Source: International Congress 2019 – Phenotypes and comorbidities of airway diseases
Year: 2019
Late Breaking Abstract - Preliminary analysis of the data of patients with severe bronchial asthma included in the Russian National Register of Severe Asthma (RSAR)
Source: International Congress 2019 – Asthma: outcomes of clinical trials and cohorts
Year: 2019
Cost analysis of childhood asthma in Iran: A cost evaluation based on referral center data for asthma and allergies
Source: International Congress 2014 – More paediatric asthma
Year: 2014
The impact of obesity in patients with severe asthma in the Wessex Severe Asthma Cohort (WSAC)
Source: Virtual Congress 2020 – Management of allergy, asthma and COPD
Year: 2020
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept